Finance

If you’ve started to live off of your nest egg, then this pair of reliable dividend payers could be a good, balanced fit for your portfolio.

The company is aiming to extend the recent momentum for its Switch console with an upgraded model coming later this year.

The local e-commerce upstart has made terrific progress in just over a year, and has plans to go bigger.

A $4.4 billion IPO, a crackdown by Chinese regulators, major fines, class-action lawsuits. Quite a week for the “Uber of China.”

Looking for stocks to buy as the world starts to come back to life? This trio is already benefiting.

Both have their advantages and disadvantages, but which one is right for you?

Shares of these Chinese fintech companies are suffering as regulators increase their oversight on Chinese companies listing on American stock exchanges.

Online dating is merging into real-life experiences.

The pandemic threw Chewy a bone, and the company ran with it.

ARK believes technology will boost the NPV of biopharmaceutical pipeline assets significantly during the next five to ten years.

ARK believes technology will boost the NPV of biopharmaceutical pipeline assets significantly during the next five to ten years.

Richard Branson’s rocket ride is about to become a reality.

Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech.

Background check data weighed the entire industry down.

They’ve just been deemed meme stocks and already are experiencing volatility.

Avis Budget Group has a lot to worry about.

The Chinese government continues its crackdown on private tutoring companies.

All of a sudden, the UAE wants out of the oil business.

A gene editing milestone sent the entire sector higher last month.

Branson’s flight will be a key moment in the company’s history.